eCOA

5 Key Takeaways from the FDA’s Real-World Evidence Guidance

EQ-5D in European Trials: When Generic QoL Measures Actually Matter

Analysis of 735 FDA drug approvals reveals 0% EQ-5D labeling inclusion, while European HTA bodies demonstrate 18% technology...

Navigating the eCOA Vendor Landscape in 2025: What Clinical Teams Really Need to Know

The eCOA market reached $2.27 billion in 2025 with 16.1% projected growth, yet vendor selection remains critical for...

Optimizing eCOA in Oncology Trials: Patient-Focused Data Capture for Cancer Research

Oncology leads clinical innovation with 7,747 trials registered through 2022, yet only 7% of cancer patients participate. This...

ePRO, eCOA 101: Everything You Need to Know About ePRO and eCOA

Electronic Clinical Outcome Assessment (ECOA) and electronic Patient Reported Outcomes (ePRO) represent far more than digital surveys in...

Why eCOA Still Fails in Clinical Trials: Practical Strategies to Fix Baseline Data Problems

Electronic clinical outcome assessments (eCOA) were supposed to solve data quality and amplify the patient voice. Yet missing...

The New Standard in Participant-Centric Trials: What Castor’s 2025 Updates Reveal About the Future of Clinical Research

Explore how Castor’s 2025 updates reduce site burden and boost compliance through scalable, flexible DTP workflows.

Do Patients Really Understand Clinical Trials?

Poor comprehension of informed consent disrupts trials. Here’s how to fix it—with data, tech, and actual patient understanding.

Why a Life Sciences Museum Matters—And What It Can Teach Us About the Future of Medicine

What a Museum of Medicine can teach us about trials, trust, and how the public sees (or doesn’t...

Strategies to Minimize Participant and Healthcare Provider Burden in Clinical Trials

This article examines strategies to reduce participant and provider burden in clinical trials while ensuring high-quality data collection....

12 November 2024

eCOA Evolution: Have We Overcomplicated What Used to Work?

A blueprint for engineering elegant eCOA solutions that make complex trials feel simple.

24 September 2024

Unlocking FDA’s Vision for PRO Collection in RWE: Timing, Methods, and Insights

Discover FDA's guidance on collecting PROs for Real-World Evidence (RWE), focusing on timing, methods, and improving data quality.

eCOA: Afterthought or Essential Strategy? An Expert’s View on Choosing and Developing an eCOA Strategy

The Evolving Landscape of eCOA in Clinical Trials Clinical trials have long grappled with the complexities of data...

Evaluating “Bother” as a Component of Patient-Reported Outcomes in Clinical Studies

Patient-reported outcome (PRO) instruments refer to multiple scales and questionnaires designed to collect patients’ personal feedback on their...

Can BYOD help us end an era of waste and burden in eCOA?

Bring Your Own Device (BYOD) represents the future of eCOA, and prioritizes flexibility & convenience for trial participants....

Measuring the true patient experience in Cancer Trials with eCOA / ePRO

Shedding light on the complexities and advancements in measuring PROs, drug tolerability, and quality of life in cancer...

The Place of COAs / PROs in the Future of Healthcare

Learn how integrating Patient-Reported Outcomes (PROs) into clinical trials can drive success in Value-Based Care (VBC).

19 November 2021

How to Incorporate Remote Technology in Your Next Medical Device Trial

Researchers are looking to incorporate remote technologies into medical device trials for a wide range of device classifications....

10 November 2020

Electronic Patient Reported Outcome (ePRO) Measures: Questionnaires & More

Patient reported outcome measures in clinical trials have traditionally been done on paper. Surveys are a common way...

Connect with us on LinkedIn

Try Castor EDC For Yourself

Start designing your own study structure and forms today.

Try Castor EDC For Yourself

Start designing your own study structure and forms today.

Try For Free